According to Reata Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is $23.48 Million USD. In 2022 the company made a revenue of $2.21 Million USD a decrease over the revenue in the year 2021 that were of $11.49 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.